Table 1 Clinical and laboratory parameters
From: The prognostic importance of the pan-immune-inflammation value in patients with septic shock
Parameter | n | Median (IQR) |
|---|---|---|
Age | 82 | 64.50 (51.00 – 77.00) |
Sex (M/F) | 43/39 | |
BMI kg/m2 | 75 | 27.13 (23.44 – 30.86) |
Diagnosis, n (%) | ||
Malignity | 12 (14.63) | |
Respiratory | 23 (28.05) | |
Operational | 10 (12.20) | |
Other | 37 (45.12) | |
Comorbidity presence, n (%) | ||
Yes | 58 (70.73) | |
No | 24 (29.27) | |
HT, n (%) | 35 (42.68) | |
DM, n (%) | 18 (21.95) | |
CVD, n (%) | 17 (20.73) | |
Presence of other diseases, n (%) | 27 (32.93) | |
GCS | 82 | 13.00 (3.00 – 15.00) |
SOFA | 82 | 7.00 (2.00 – 12.00) |
APACHE II | 81 | 17.00 (9.00 – 24.00) |
Lactate mmol/L | 82 | 1.80 (1.10 – 3.40) |
Neutrophil × 103/μL | 82 | 10.00 (7.30 – 13.20) |
Monocyte × 103/μL | 82 | 0.50 (0.40 – 0.90) |
Platelet × 103/μL | 82 | 192.50 (127.00 – 244.00) |
Lymphocyte × 103/μL | 82 | 0.90 (0.60 – 1.60) |
PIV × 106/μL | 82 | 1174.17 (489.70 – 2341.73) |
CRP mg/L | 82 | 94.74 (40.2–166) |
PCT µg/L | 82 | 0.72 (0.24 – 5.27) |
Mortality, n (%) | 32 (39.02) | |